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Abstract
Background. Children with chronic kidney disease (CKD) are characterized by increased risk of hypertension and 
chronic low-grade inflammation. The aim of the study was the analysis of relation between parameters of ambulatory 
blood pressure monitoring (ABPM) and subclinical inflammation in children with CKD. 
Material and methods. Study group included 27 paediatric patients (age 14.23 ± 3.57 years) with CKD stage 2–5; 
18 children with previously recognized hypertension. In all patients we evaluated ABPM, office blood pressure, 
complete blood count and selected clinical and biochemical parameters. 
Results. In the study group, GFR was from 7.05 to 86.73, mean 40.88 ± 25.82 mL/min/1.73 m2. All 9 children 
without hypertension had normal blood pressure in ABPM, but ABPM detected poor blood pressure control in 7 
among 18 (38.9%) children with previously recognized and treated hypertension. Abnormal circadian blood pressure 
profile was found in 12 (44.4%) children: 9/18 (50.0%) with hypertension and 3/9 (33.3%) with normal BP. Systo-
lic, diastolic, mean blood pressure and diastolic blood pressure load correlated with neutrophil count, neutrophil-
to-lymphocyte ratio and platelet-to-lymphocyte ratio (r = 0.39–0.49, p = 0.010–0.044); diastolic and mean blood 
pressure and diastolic blood pressure load with parathormone (r = 0.48–0.57, p = 0.005–0.023); diastolic blood 
pressure load with phosphate and calcium-phosphorus product (r = 0.44–0.47, p = 0.021-0.030); diastolic blood 
pressure dipping with phosphate (r = –0.43, p = 0.034).
Conclusions. 1. Ambulatory blood pressure monitoring should be used in children with chronic kidney disease on a 
regular basis, especially in those with arterial hypertension. 2. Blood pressure in children with chronic kidney disease 
may be related to degree of subclinical inflammation. 
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Introduction
Cardiovascular disease (CVD) is a leading cause of 
mortality in children with chronic kidney disease 
(CKD). The burden of CVD in children with CKD 
can be explained by accumulation of both traditional 
(hypertension, dyslipidaemia, obesity) and non-tradi-
tional, referred to as uraemia-related, risk factors (anae-
mia, albuminuria, abnormal mineral metabolism, over-
hydration, and subclinical inflammation) [1]. 
Twenty-four-hour ambulatory blood pressure 
monitoring (ABPM) was found to be superior to 
casual (office) blood pressure measurement in detec-
tion of abnormal blood pressure. In many studies in 
adult and paediatric populations ABPM parameters 
showed better correlation with target organ damage 
compared to office measurements. High blood pres-
sure variability, disturbed circadian blood pressure 
rhythm, and increased pulse pressure were found 
to be additional risk factors for the development of 
target organ damage [2]. Also based on ABPM data, 
the ambulatory arterial stiffness index (AASI) was 
proposed as a marker of arterial compliance [3]. 
The variety of factors contribute to  chronic  in-
flammatory status in patients with CKD, including 
increased production and decreased clearance of pro-
inflammatory cytokines, oxidative stress, acidosis, 
infections, including those related to dialysis access, 
altered metabolism of adipose tissue, and intestinal 
dysbiosis. The inflammation was found to correlate 
negatively with the glomerular filtration rate (GFR) 
in CKD and culminates in dialysis patients, where 
extracorporeal and bioincompatible factors (dialy-
sis water, microbiological quality of the dialysate, 
dialyzer membranes) in the dialysis circuit play an 
additional role [4]. 
Neutrophil count, neutrophil-to-lymphocyte ra-
tio, platelet-to-lymphocyte ratio, and mean platelet 
volume are easy accessible, complete blood count 
(CBC)-derived inflammatory markers that were 
found to correlate with blood pressure and target 
organ damage in adult patients with cardiovascular 
diseases [5–9]. 
There are only few data on relation between hy-
pertension, cardiovascular risk and inflammation 
in patients with chronic kidney disease [6, 7, 10]. 
Preliminary data suggest positive relation between 
degree of subclinical inflammation and cardiovas-
cular burden in these patients, as concentration of 
highly-sensitive CRP (hsCRP) was found to correlate 
positively with both systolic and diastolic blood pres-
sure [10].
To the best of our knowledge there are no data on 
relation between blood pressure measured by ABPM 
and CBC-derived inflammatory markers in children 
with CKD.
Thus, the aim of our study was to analyse the rela-
tion between results of ambulatory blood pressure 
monitoring and subclinical inflammation in children 
with CKD.
Material and methods
We analysed retrospectively clinical data of 27 chil-
dren and adolescents with chronic kidney disease 
stages G2–G5 according to KDIGO (Kidney Dis-
ease Improving Global Outcome) classification [11] 
treated in one tertiary centre of paediatric nephrol-
ogy. Children with coexisting congenital or acquired 
heart defects and children with acute infections or 
other evident sources of inflammation were excluded 
from the study.
The following clinical data were collected from 
all CKD patients: age [years]; gender, aetiology of 
CKD according to ESPN/ERA-EDTA (European 
Society for Paediatric Nephrology/European Renal 
Association-European Dialysis and Transplantation 
Association) Registry (www.espn-reg.org/index.jsp); 
CKD stage according to KDIGO classification [11] 
based on estimated glomerular filtration rate (eGFR) 
derived by the modified Schwartz formula [12]; body 
mass [kg]; height [m] and body mass index (BMI) 
[kg/m2] (Z-scores were calculated from national nor-
mative data [13]); hypertension diagnosed according 
to Polish Society of Hypertension guidelines [14]; 
and medications that might affect cardiovascular sys-
tem. Overweight and obesity were defined according 
to World Health Organization definitions as BMI 
Z-score values > 1 and > 2, respectively.
Peripheral blood pressure was measured using os-
cillometric device (Welch Allyn VSM Patient Moni-
tor 300, Welch Allyn, USA). Obtained values were 
expressed as [mm Hg] and were compared with nor-
mative values [15] and expressed as Z-score. 
Twenty-four-hour blood pressure measurement 
was performed using a SUNTECH OSCAR 2 
device (SunTech Medical, Inc., Morrisville, NC, 
USA) and interpreted according to the American 
Heart Association (AHA) guidelines. Monitors 
were programmed to measure blood pressure every 
15 minutes from 6 AM to 10 PM and every 30 
minutes from 10 PM to 6 AM. Periods of night-
time rest and daytime activity were determined 
individually by providing data in a diary. Follow-
ing parameters were evaluated based on ABPM: 
systolic, diastolic, and mean arterial pressure (SBP, 
DBP, MAP) during 24 hours [mm Hg]; pulse pres-
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sure (PP) during 24 hours [mm Hg]; systolic and 
diastolic blood pressure load during 24 hours [%]; 
nocturnal blood pressure dip (%); blood pressure 
variability; and AASI. Pulse pressure was calculated 
as the difference between mean SBP and DBP dur-
ing 24 hours, blood pressure load as a percentage 
of measurements ≥ 95th percentile during 24 hours 
and increased load was defined as > 25% [2]. AASI 
was calculated as 1 minus correlation coefficient 
between diastolic and systolic blood pressure values 
over 24 hours in ABPM [3]. Nocturnal systolic 
and diastolic blood pressure dip (SBP DIP, DBP 
DIP, respectively) was calculated as the difference 
between daytime pressure and nighttime pressure 
expressed as a percentage of the day value. Dis-
turbed circadian blood pressure rhythm was defined 
as nocturnal systolic or diastolic blood pressure dip 
less than 10%. Blood pressure variability was calcu-
lated as standard deviation (SD) from the mean of 
all systolic or diastolic blood pressure values over 24 
hours (SD SBP/24h, SD DBP/24h) [2].
In all the studied children peripheral automated 
complete blood count was performed using Coul-
ter LH 780 hematologic analyser (Beckman Coul-
ter Inc., Brea, CA, USA). Following parameters 
of CBC were evaluated: haemoglobin concentra-
tion (Hb) [g/dL], number of neutrophils (NEU) 
[ths/µL], number of lymphocytes (LYM) [ths/µL], 
number of platelets (PLT) [ths/µL], mean platelet 
volume (MPV) [fL], neutrophil-to-lymphocyte ra-
tio (NLR), and platelet-to-lymphocyte ratio (PLR). 
In addition, serum concentrations of the follow-
ing biochemical parameters were assessed: creati-
nine [mg/dL], urea [mg/dL], uric acid [mg/dL], 
total, low-density lipoprotein and high-density li-
poprotein cholesterol [mg/dL], calcium [mg/dL], 
inorganic phosphate [mg/dL], alkaline phosphatase 
[IU/mL], intact parathormone [pg/mL], 25-hy-
droxy-vitamin D (25(OH)D) [ng/mL]. iPTH was 
measured using a solid-phase, two-site chemilumi-
nescent enzyme-labelled immunometric assay, IM-
MULITE 2000, Siemens. 25(OH)D was assessed 
using a one-step delayed chemiluminescent mic-
roparticle immunoassay, ARCHITECT i1000SR, 
Abbott. The remaining biochemical variables were 
measured using VITROS 5600 Integrated System, 
Ortho Clinical Diagnostics. Patients’ biochemical 
data were compared with KDIGO recommended 
values (haemoglobin) [16], and European Paediatric 
Dialysis Working Group (EPDWG) guidelines (cal-
cium-phosphorus metabolism) [17]. According to 
Polish recommendations vitamin D concentrations 
were defined as: severe deficiency (0–10 ng/mL), 
deficiency (> 10–20 ng/mL), suboptimal (> 20–30 
ng/mL), optimal (> 30–50 ng/mL), high (> 50–100 
ng/ml), and toxic (> 100 ng/mL) levels [18]. Nor-
mal concentrations of calcium (8.8–10.7 mg/dL), 
phosphate (2.8–5.6 mg/dL), alkaline phosphatase 
(45–515 IU/L), and parathormone (12–95 pg/mL) 
were taken from normative values in accordance 
with producer’s recommendations. Hypoalbumin-
emia was defined as serum albumin concentration 
< 3.5 g/dL, hyperuricemia as uric acid > 6.0 mg/dL, 
hypercholesterolemia as cholesterol ≥ 200 mg/dL, 
and hypertriglyceridemia as triglyceride ≥ 100 mg/dL 
(children aged 0–9 years) or ≥ 130 mg/dL (children 
aged 10–19 years). 
Additionally, low-sensitivity C-reactive protein 
was measured in the studied children using VITROS 
5600 Integrated System and was within normal lim-
its (< 1.0 mg/dL) in all the participants.
All procedures were performed in accordance with 
the Declaration of Helsinki on the treatment of hu-
man subjects. Due to retrospective nature of the 
study formal informed consent was not required. 
Statistical analysis
Statistical elaboration was performed using Dell Sta-
tistica 13.0 PL software (Dell Inc., AlisoViejo, CA, 
USA). Variables were presented as the mean ± stan-
dard deviation (SD). Normality of data distribution 
was tested using the Shapiro-Wilk test. Correlations 
between parametric and non-parametric variables 
were evaluated using the Pearson and the Spearman 
rank correlation, respectively. A p-value < 0.05 was 
considered statistically significant.
Results
The clinical characteristics of children included in 
the study are presented in Table I. The most common 
cause of CKD were congenital anomalies of the kid-
ney and the urinary tract (CAKUT), followed by glo-
merular disorders (Henoch-Schoenlein nephropathy 
in 2, IgA nephropathy in 1, membrano-proliferative 
nephropathy in 1 and focal and segmental glomeru-
losclerosis in 1). Among five patients with CKD stage 
5, three received renal replacement therapy (RRT). 
One child was overweight, 2 children were obese 
and 2 were underweight (with BMI Z-score below 
–2). Two thirds of CKD children had hypertension, 
among which most patients received at least 2 anti-
hypertensive medications. Dihydropyridine calcium 
channel blockers (CCBs) were most frequently used 
medications. Two children without hypertension 
received angiotensin converting enzyme inhibitors 
(ACEIs) as a renoprotective treatment; the same two 
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patients received doxazosin as a treatment of urinary 
bladder dysfunction. Three children with glomerular 
kidney diseases were treated with prednisone.  
Blood pressure measurements are presented in 
Table II. All 9 children without hypertension had 
normal blood pressure in ABPM, but ABPM de-
tected poor blood pressure control in 7 among 18 
(38.9%) children with previously recognized and 
treated hypertension. Abnormal circadian profile of 
blood pressure was found in 12 (44.4%) children: 
3/9 (33.3%) with normal BP and 9/18 (50.0%) with 
hypertension.
Complete blood count, CBC-derived inflamma-
tory markers, and biochemical parameters are pre-
sented in Table III. Anaemia was found in 5 (19%) 
children, hyperuricemia in 11 (41%), hypercholes-
terolemia in 2 (7%), and hypertriglyceridemia in 6 
(22%) patients. Serum calcium was within normal 
limits in all studied children, whereas serum phos-
phate was increased in 4 (15%) patients. Calcium-
phosphorus product was elevated in 2 (7%) patients 
and was normal in the remaining children. Vitamin 
D deficiency was found in 9 (33%) children. Serum 
iPTH was lowered in 2 (7%), and elevated in 9 
(33%) patients, and alkaline phosphatase was normal 
in all the patients. 
Correlations of ABPM parameters with inflam-
matory markers and parathormone are presented in 
Table IV. Systolic, diastolic and mean blood pressure, 
as well as diastolic blood pressure load during 24 
hours correlated positively with CBC-derived in-
flammatory markers: neutrophil count, neutrophil-
to-lymphocyte ratio, and platelet-to-lymphocyte ra-
tio. Diastolic and mean blood pressure and diastolic 
blood pressure load also correlated positively with 
level of parathyroid hormone. Inflammatory mark-
ers did not correlate with age in the study group. 
In addition, diastolic blood pressure load during 24 
hours correlated positively with phosphate (r = 0.47, 
Table I. Clinical characteristics of children with chronic kidney 
disease
Analysed parameter CKD patients
Number of patients (n) 27
Age [years] 14.23 ± 3.57  
(from 4.83 to 17.92)
Gender (males / females) 16/11
CKD aetiology [n (%)]
CAKUT
Glomerulonephritis
Hereditary nephropathy
Toxic/ischaemic kidney injury
Cystic kidney disease
Haemolytic-uremic syndrome
10 (37%)
5 (19%)
2 (7%)
3 (11%)
4 (15%)
3 (11%)
CKD stage [n (%)]
2
3
4
5
8 (30%)
7 (26%)
7 (26%)
5 (18%)
Renal replacement therapy [n (%)]
Automated peritoneal dialysis
Peritoneal dialysis
3 (11%)
2
1
BMI Z-score –0.21 ± 1.34
Hypertension [n (%)] 18 (67%)
Antihypertensive medications [n (%)]
Calcium channel blockers
Angiotensin converting enzyme inhibitors
Beta-blockers
Alpha-blockers
Angiotensin receptor blockers
Hydrochlorothiazide
16 (59%)
12 (44%)
5 (19%)
3 (11%)
1 (4%)
1 (4%)
Number of antihypertensive medications in 
children with hypertension [n (%)]
1
2
3
1.83 ± 0.62
5 (28%)
11 (61%)
2 (11%)
Cholecalciferol [n (%)] 18 (67%)
Alphacalcidol [n (%)] 11 (41%)
CaCO3 [n (%)] 12 (44%)
NaHCO3 [n (%)] 6 (22%)
Erythropoiesis-stimulating agents [n (%)] 6 (22%)
Recombinant human growth hormone [n 
(%)]
3 (11%)
Prednisone [n (%)] 3 (11%)
CKD — chronic kidney disease; CAKUT — congenital anomalies of kidney and urinary tract;  
BMI — body mass index
Table II. Blood pressure measurements in the studied children
Office blood pressure
Systolic blood pressure [mm Hg]
Systolic blood pressure Z-score
117.24 ± 13.90
0.79 ± 1.31
Diastolic blood pressure [mm Hg]
Diastolic blood pressure Z-score
73.67 ± 12.43
0.87 ± 1.03
24-hour ambulatory blood pressure monitoring
Systolic blood pressure during 24 h [mm Hg] 122.19 ± 9.66
Diastolic blood pressure during 24 h [mm Hg] 70.63 ± 10.09
Mean blood pressure during 24 h [mm Hg] 87.85 ± 9.50
Pulse pressure during 24 h [mm Hg] 51.41 ± 7.06
SBP load during 24 h (%) 34.07 ± 27.87
DBP load during 24 h (%) 25.70 ± 29.89
SBP variability 11.50 ± 2.10
DBP variability 10.25 ± 1.94
SBP dipping (%) 10.27 ± 4.28
DBP dipping (%) 15.91 ± 7.69
Ambulatory arterial stiffness index 0.32 ± 0.10
SBP — systolic blood pressure; DBP — diastolic blood pressure
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p = 0.021) and calcium-phosphorus product (r = 0.44, 
p = 0.030). We found also positive correlation of 
pulse pressure during 24 hours with haemoglobin 
(r = 0.50, p = 0.008), and positive correlation of 
heart rate during 24 hours with platelet count 
(r = 0.51, p = 0.007). We found also negative cor-
relation of diastolic blood pressure dipping with 
phosphate (r = –0.43, p = 0.034). Ambulatory arte-
rial stiffness index correlated significantly only with 
lymphocyte count (r = 0.52, p = 0.019). We found 
no other significant correlations of AASI with clinical 
and biochemical parameters in the study group.
We also found positive correlations between of-
fice blood pressure measurements and inflammatory 
indicators: diastolic blood pressure expressed as both 
[mm Hg] and Z-score correlated with neutrophil 
count (r = 0.60, p = 0.004 and r = 0.59, p = 0.004) 
and with NLR (r = 0.57, p = 0.006 and r = 0.61, 
p = 0.003).
In our study group, calcium correlated positive-
ly with lymphocyte and platelet count (r = 0.41, 
p = 0.036 and r = 0.50, p = 0.009). No other sig-
nificant correlations between inflammatory markers 
and parameters of calcium-phosphorus metabolism 
including vitamin D concentration were found.
Discussion 
Analysis of blood pressure monitoring in our group 
of children with chronic kidney disease revealed 
poor control of previously recognized hyperten-
sion in more than two thirds of patients. According 
to American Heart Association guidelines, ABPM 
should be regularly used in children with CKD, 
also in those with normal blood pressure in office 
measurements [2]. Children with CKD are prone to 
develop nighttime hypertension and masked hyper-
tension which cannot be detected in office measure-
ments [19]. Though we have not found any patients 
with masked hypertension, ABPM enabled detection 
of poor control in many hypertensive children. It 
must be emphasized that masked hypertension is 
almost as strong predictor of left ventricular hyper-
trophy as office hypertension, which was proven both 
for children with primary hypertension [20] and 
Table III. Biochemical parameters in the study group
Parameter Study group
Haemoglobin [g/dL] 12.71 ± 1.96
Neutrophils [ths/μL] 4.36 ± 2.46
Lymphocytes [ths/μL] 2.27 ± 0.81
Platelets [ths/μL] 233.33 ± 59.11
NLR 2.48 ± 2.96
PLR 118.61 ± 74.24
Mean platelet volume [fL] 9.06 ± 1.69
GFR [mL/min/1.73m2] 40.88 ± 25.82  
(from 7.05 to 86.73)
Urea [mg/dL] 75.74 ± 45.54
Uric acid [mg/dL] 7.05 ± 2.37
Total cholesterol [mg/dL] 175.80 ± 31.82
Triglyceride [mg/dL] 191.17 ± 91.71
Calcium [mg/dL] 9.89 ± 0.51
Inorganic phosphate [mg/dL] 4.95 ± 0.85
Calcium-phosphorus product [mg2/dL2] 48.96 ± 7.76
25(OH)D [ng/mL] 19.43 ± 8.17
Intact parathormone [pg/mL] 146.23 ± 170.14
Alkaline phosphatase [U/L] 180.18 ± 82.33
pH 7.39 ± 0.04
HCO3– [mmol/L] 23.02 ± 3.50
NLR — neutrophil-to-lymphocyte ratio; PLR — platelet-to-lymphocyte ratio; GFR — glomerular filtration 
rate
Table IV. Correlations of blood pressure parameters and age with inflammatory indicators and parathormone
NEU [1000/µL] NLR PLR iPTH [pg/mL]
SBP 24h 
[mm Hg]
r = 0.39 
p = 0.042
r = 0.40 
p = 0.040
r = 0.45 
p = 0.019
r = 0.25 
p = 0.255
DBP 24h
[mm Hg]
r = 0.47 
p = 0.013
r = 0.42 
p = 0.029
r = 0.46 
p = 0.016
r = 0.53 
p = 0.010
MAP 24h
[mm Hg]
r = 0.49 
p = 0.010
r = 0.44 
p = 0.021
r = 0.48 
p = 0.011
r = 0.48 
p = 0.023
DBPL 24h
[mm Hg]
r = 0.47 
p = 0.013
r = 0.40 
p = 0.041
r = 0.39 
p = 0.044
r = 0.57 
p = 0.005
Age 
[years]
r = 0.17 
p = 0.393
r = 0.10 
p = 0.612
r = -0.08 
p = 0.695
r = 0.03 
p = 0.887
NEU — neutrophil count; NLR — neutrophil-to-lymphocyte ratio; PLR — platelet-to-lymphocyte ratio; iPTH — intact parathormone; SBP 24h — systolic blood pressure during 24 hours; DBP 24h — diastolic blood pres-
sure during 24 hours; MAP 24h — mean arterial pressure during 24 hours; DBPL 24h — diastolic blood pressure load during 24 hours
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with hypertension in the course of CKD [21]. Our 
results highlight the need for regular ABPM evalua-
tion in children with chronic kidney disease.
Abnormal circadian blood pressure profile was 
revealed in almost half of our patients. Our results 
are in accordance with results of other studies ana-
lysing ABPM results in children with CKD. Mitsne-
fes found abnormal systolic blood pressure dipping 
in 59% and abnormal diastolic dipping in 31% of 
children with chronic renal insufficiency [22]. It is 
hypothesized that disturbed circadian blood pres-
sure profile in patients with kidney diseases might be 
caused by increased sympathetic activity due to stim-
ulation by afferent renal fibres. More frequent target 
organ damage such as left ventricular hypertrophy 
was observed in children with disturbed circadian 
blood pressure profile [23]. Moreover, many studies 
showed that nocturnal hypertension is an indepen-
dent risk factor for kidney function decline [24].
We have found significant positive correlations be-
tween blood pressure evaluated by ABPM and com-
plete blood count-derived inflammatory markers: 
neutrophil count, neutrophil-to-lymphocyte ratio, 
and platelet-to-lymphocyte ratio. In addition, office 
diastolic blood pressure correlated with neutrophil 
count and NLR. Obviously, both blood pressure 
values and parameters of blood morphology are age-
dependent. Though, this relation is not distorted 
by age, as all these inflammatory indicators did not 
correlate with age in our cohort. Moreover, this rela-
tion was still present when office blood pressure was 
expressed as Z-score. 
Neutrophils are the most abundant type of white 
blood cells and the first cells responding to inflam-
mation, especially if it is caused by a bacterial infec-
tion or environmental exposure like burns. They 
release many cytokines that trigger and amplify in-
flammatory reactions. Neutrophil-to-lymphocyte ra-
tio is an inexpensive, reproducible test and has shown 
up as a marker of systemic inflammatory response. 
Adult studies have shown that high NLR is associ-
ated with poor clinical outcomes in cardiac diseases 
[5]. While high neutrophil count reflects inflam-
mation, low lymphocyte count reflects poor general 
health and physiological stress. Large platelets are 
more active metabolically and enzymatically, and 
they have increased thrombotic potential in compari-
son to small platelets. Elevated mean platelet volume 
and increased platelet count were found to be mark-
ers of cardiovascular diseases such as acute coronary 
syndromes [8] and hypertension [9]. Thus, blood 
NLR, PLR and MPV are indicators of the overall in-
flammatory and stress status of the body. Binnetoglu 
found that both NLR and PLR were predictors of 
proteinuria in CKD subjects [6] and Taymez revealed 
that elevated PLR is and independent indicator of 
erythropoietin resistance in adult patients treated 
with chronic haemodialysis [25]. Finally, NLR and 
PLR were found to be associated with all-cause mor-
tality in prevalent HD patients [26]. Our results 
indicate pathophysiological relation between NLR, 
PLR and blood pressure also in paediatric patients 
with chronic kidney disease. 
Sunbul et al. found that adult patients with non-
dipper hypertension had significantly higher NLR 
and PLR compared to dipper hypertension. More-
over, PLR of more than 107 but not NLR was in-
dependent predictor of non-dipper status [5]. Also 
higher MPV, PLR and NLR were related to non-
dipping status in hypertensive adult patients with 
CKD [7]. In our small group of patients we did 
not find any significant relations between nighttime 
blood pressure dip and inflammatory indicators. 
In our cohort, we have found positive correla-
tions between blood pressure and parathormone, 
phosphate, and calcium-phosphorus product. In ad-
dition, phosphate correlated negatively with night-
time blood pressure dipping. Phosphate is considered 
nowadays as one of the most lethal uremic toxins 
with highly negative impact on arterial wall in pa-
tients with CKD. Increased phosphataemia and 
high calcium-phosphorus product lead to medial 
calcification, known as Mönckeberg’s sclerosis. Clini-
cal consequences of medial calcification include in-
creased vascular stiffness, systolic hypertension and 
left ventricular hypertrophy [27]. Noteworthy, both 
high-turnover bone disease (with high parathormone 
levels) and low-turnover bone disease (with low para-
thormone levels) promote vascular wall calcification. 
Surprisingly, in our cohort indices of mineral me-
tabolism correlated with diastolic not with systolic 
blood pressure. Opposite to our results, Vyssoulis et 
al. in a study of hypertensive adults found positive 
relation between phosphate concentration and dip-
ping status — highest phosphate status was revealed 
in “extreme” dippers [28].  
Both observational and experimental studies re-
vealed association of vitamin D with markers of 
inflammation. Studies in adult patients with CKD 
suggest link between vitamin D deficiency, degree of 
inflammation and anaemia and erythropoietin hy-
poresponsiveness [29], as well as albuminuria [30]. 
Moreover, paricalcitol, a selective vitamin D recep-
tor activator, was found to reduce hsCRP, tumour 
necrosis factor-alpha (TNF-a) and interleukin 6 
(IL-6) in CKD adult patients [31]. On the contrary, 
in our small cross-sectional study we have not found 
significant relations between vitamin D concentra-
arterial hypertension 2019, vol. 23, no. 1
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tion and markers of inflammation (NLR, PLR and 
MPV).  
Ambulatory arterial stiffness index is an ABPM-
derived marker of arterial compliance [3]. In our 
cohort we failed to find any significant determinants 
of AASI, except for elevated lymphocytes. According 
to literature, arterial stiffness in children with CKD 
was related to high blood pressure [32], low GFR 
and low vitamin D status [33]. These differences 
might be a consequence of small patient number or 
other, indirect method of evaluation of arterial stiff-
ness, compared to aforementioned studies.
Limitation of our study is small patient sample, 
which could have precluded disclosure of some rela-
tions between ABPM parameters and inflammatory 
indicators. We also did not evaluate hsCRP or cyto-
kine concentration (e.g. IL-6 or TNF-a), which are 
well-established and more precise markers of subclin-
ical inflammation. There is a need for further stud-
ies (including prospective trials) on mutual relation 
between cardiovascular burden and subclinical in-
flammation in children with chronic kidney disease. 
Conclusions
1. Ambulatory blood pressure monitoring should 
be used in children with chronic kidney disease 
on regular basis, especially in those with arterial 
hypertension.
2. Blood pressure in children with chronic kidney 
disease may be related to degree of subclinical 
inflammation. 
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